News and Press Releases

Sparking change for women’s health: 11 promising femtech start-ups descend on Discovery Park, kicking off 2024 business support programme

The Femtech & Women’s Health edition of ‘Discovery Spark’ champions early stage businesses working to close the gender health gap 30 May 2024 -- Kent, UK -- Discovery Park, Kent’s...

Category: Biotechnology, Pharmaceutical
Posted: May 30, 2024

Discovery Park, Innovation House, Sandwich, Kent, CT13 9FF

New CAS BioFinder Discovery Platform empowers drug discovery scientists to reveal insights, drive innovation and save time

Transformative new scientific information capabilities combine an unparalleled collection of curated science data with advanced predictive models to accelerate early-stage drug discovery innovation 21 May 2024 – Columbus, OH, US...

Category: Drug Discovery
Posted: May 30, 2024

1155 Sixteenth Street, NW, Washington, DC 20036, US

Biogen Receives European Commission Approval for QALSODY (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS

SOD1-ALS is a devastating, uniformly fatal and ultra-rare genetic form of ALS estimated to affect less than 1,000 people in Europe QALSODY is Biogen’s third rare disease therapy to be...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: May 30, 2024

Biogen International GmbH Neuhofstrasse 30 6340 Baar Switzerland

Asymchem welcomes Franck Mevellec as senior director of Business Development

29 May 2024 -- Paris, France --  Asymchem, a leading global CDMO, is excited to announce the appointment of Franck Mevellec as senior director of business development. Franck brings over...

Category: BioManufacturing, Drug Discovery, Pharmaceutical
Posted: May 29, 2024

Asymchem Laboratories (Tianjin) Co., Ltd No. 6 Dongting 3rd Avenue, TEDA Tianjin, 300457, P.R. China

ModeX Therapeutics Leverages ProBioGen’s Expertise for Accelerated COVID-19 Antibody Development

29 May 2024 -- Berlin, Germany -- ProBioGen, a leading contract development and manufacturing organisation (CDMO), known for its innovative solutions in cell engineering and bioprocessing excellence, announces a pivotal...

Category: BioManufacturing, Biotechnology, Pharmaceutical
Posted: May 29, 2024

20 Riverside Road Weston, MA 02493

Cellular Origins and Cell and Gene Therapy Catapult collaborate to demonstrate universal automation of CGT manufacturing

Partnership to develop and implement Cellular Origins’ robotic platform Constellation for universal automation of CGT manufacturing at CGT Catapult’s Stevenage Manufacturing Innovation Centre, UK 29 May 2024 -- Cambridge, UK,...

Category: BioManufacturing, Biotechnology, Drug Discovery
Posted: May 29, 2024

TTP Campus Cambridge Road Melbourn SG8 6HQ

Rentschler Biopharma appoints Patrick Meyer as global head BD Sales and Alliance Management

28 May 2024 – Laupheim, Germany; Milford, MA, US; and Stevenage, UK – Rentschler Biopharma SE, a leading global contract development and manufacturing organisation (CDMO) for biopharmaceuticals, including advanced therapy...

Category: Biotechnology
Posted: May 29, 2024

Erwin-Rentschler-Str. 21 88471 Laupheim Germany

Independent research demonstrates the extreme safety of Bormioli Pharma’s bottles manufactured with Loop Industries’ 100% recycled, virgin quality PET

Developed from PET resin supplied by Loop Industries, Inc., the containers have extractables values well below even conventional solutions in virgin PET under the most challenging conditions. 28 May 2024...

Category: Manufacturing and Packing
Posted: May 29, 2024

Via Tortona 48, 27055 Rivanazzano Terme (PV)

Secarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide therapeutics

Partnership expands spectrum of Secarna’s capabilities for the development of targeted ASOs beyond antibodies and sugar molecules New platform capabilities extend the reach of Secarna’s antisense approaches, potentially offering new...

Category: Biotechnology, Pharmaceutical
Posted: May 28, 2024

Am Klopferspitz 19 82152 Planegg / Martinsried Germany

Exonate appoints Dr Rafiq Hasan as Non-Executive Director

Appointment brings extensive experience in global pharma leadership and progressing ophthalmology drugs to market and further strengthens Board 28 May 2024 -- Cambridgeshire, UK -- Exonate, a biotechnology company developing...

Category: Biotechnology, Pharmaceutical
Posted: May 28, 2024

WTL Moorfield Rd Duxford Cambridgeshire CB22 4PS United Kingdom

ACHEMA 2024: Steriline upgrades its zero-loss philosophy

Flexibility, robotics and waste minimisation for a more sustainable and time-saving production of drugs 7 May 2024 – Frankfurt, Germany – ACHEMA 2024, the World Forum for the Process Industries...

Category: BioManufacturing, Manufacturing and Packing
Posted: May 23, 2024

Via Tentorio, 30/31 22100, Como

Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024

23 May 2024 -- Tokyo, Japan -- Eisai Co announced today the presentation of research across multiple types of cancer from its oncology portfolio and pipeline during the 2024 American...

Category: Clinical Trials, Drug Discovery
Posted: May 23, 2024

4-6-10 Koishikawa, Bunkyo-ku, Tokyo 112-8088, Japan

Record numbers expected at CPHI & PMEC China 2024 as Asian markets boom

Domestic and international markets in Asia surging as CPHI & PMEC China welcomes 60,000 attendees and 3500 exhibitors 23 May 2024 - Shanghai, China and Amsterdam, The Netherlands - CPHI...

Category: Biotechnology, Drug Discovery, Manufacturing and Packing
Posted: May 23, 2024

5 Howick Place, London SW1P 1WG

Sphere Fluidics appoints Curtis Nicholson as director of Sales, EMEA, to support accelerated growth in key markets

23 May 2024 -- Cambridge, UK -- Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the appointment of Curtis Nicholson as director...

Category: Biotechnology, Pharmaceutical
Posted: May 23, 2024

The Jonas Webb Building, Babraham Research Campus, Babraham, Cambridge CB22 3AT, United Kingdom

Global oncology trial investigator sites increase by half in five years, finds new Phesi analysis

China flagged as significant contributor to growth, but poor investigator selection is causing trial failures 23 May 2024 -- Massachusetts, US -- Phesi, a leading clinical development analytics company, has...

Category: Biotechnology, Clinical Trials
Posted: May 22, 2024

East Lyme, Connecticut, US